Form 4 Filing for Boston Scientific Corp - Insider Transaction

This filing details a transaction by Jonathan Monson, EVP and CFO of Boston Scientific Corp. On July 1, 2026, Monson acquired 2,087 shares of Common Stock through the settlement of Restricted Stock Units at a price of $0.00 per share, resulting in a post-transaction holding of 40,073 shares. Concurrently, Monson disposed of 1,010 shares of Common Stock at a price of $43.06 per share, leaving a post-transaction balance of 39,063 shares. The Restricted Stock Units vest in four equal annual installments starting July 1, 2026, with each unit representing one share of common stock. The disposal of vested RSUs occurred on the same day as the acquisition, indicating a net change in holdings.